NEAT1 and neoplasm: NEAT1 shows typical features of tumor drivers because it can be involved in cancer initiation and progression, and its abnormal expression is associated with clinical characteristics including metastasis, therapy resistance, and patient survival (Snyder et al. 2022; Knutsen et al. 2022).